Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Aptose Biosciences, Inc. (APTOF) had Debt to Capital Ratio of -18.24 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-7.63M |
|
-- |
|
-- |
|
$7.18M |
|
$-7.18M |
|
$-0.45M |
|
$-7.63M |
|
$-7.63M |
|
$-7.63M |
|
$-7.63M |
|
$-7.63M |
|
$-7.63M |
|
$-7.18M |
|
$-7.18M |
|
2.55M |
|
2.55M |
|
$-2.99 |
|
$-2.99 |
|
| Balance Sheet Financials | |
$6.16M |
|
$0.00M |
|
$4.57M |
|
$10.72M |
|
$11.24M |
|
$32.87M |
|
$34.16M |
|
$45.40M |
|
$-34.67M |
|
$-34.67M |
|
$-34.67M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-5.84M |
|
-- |
|
$5.85M |
|
$4.10M |
|
$4.11M |
|
$0.01M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.55 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-18.24 |
-0.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
22.02% |
|
22.02% |
|
-71.19% |
|
423.64% |
|
$-13.59 |
|
$-2.29 |
|
$-2.29 |
|